Mantle cell lymphoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
=== Study of choice === | === Study of choice === | ||
Tissue biopsy is the gold standard test for the diagnosis of mantle cell lymphoma. | * Tissue biopsy is the gold standard test for the diagnosis of mantle cell lymphoma. For detailed microscopic findings, | ||
===== Diagnostic results ===== | ===== Diagnostic results ===== |
Revision as of 20:47, 11 December 2018
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma diagnostic study of choice |
Risk calculators and risk factors for Mantle cell lymphoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2]
Overview
Diagnostic Study of Choice
Study of choice
- Tissue biopsy is the gold standard test for the diagnosis of mantle cell lymphoma. For detailed microscopic findings,
Diagnostic results
The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:
- [Finding 1]
- [Finding 2]
Sequence of Diagnostic Studies
The [name of investigation] must be performed when:
- The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
- A positive [test] is detected in the patient, to confirm the diagnosis.
OR
The various investigations must be performed in the following order:
- [Initial investigation]
- [2nd investigation]
Name of Diagnostic Criteria
There are no established criteria for the diagnosis of [disease name].